As of 2025-05-18, the Fair Value of Moberg Pharma AB (publ) (MOB.ST) is -26.64 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.57 SEK, the upside of Moberg Pharma AB (publ) is -410.9%.
With the market price of 8.57 SEK and our fair value calculation, Moberg Pharma AB (publ) (MOB.ST) is not a good investment. Investing in MOB.ST stocks now will result in a potential loss of 410.9%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
Historical Earnings | ||||||
12-2020 | 12-2021 | 12-2022 | 12-2023 | 12-2024 | 5Y Avg | |
Net income | 8.8 | 7.49 | -15.71 | -21.09 | -255.11 | -55 |
YoY growth | -56.1% | -14.8% | -309.7% | -34.3% | -1109.5% | -304.9% |
Market Cap (mil) | 410 |
P/E | - |
Forward P/E | - |
EPS | -5.33 |
Avg earnings growth rate | -304.9% |
TTM earnings | -255 |
Peter Lynch is one of the most legendary investors/fund managers of all time. His philosophy for stock investing is very simple and straightforward: he invests in stocks that are undervalued, meaning its P/E is less than or equal to its earnings growth rate. He believes that if a stock is trading at its fair value, the PEG ratio, which was also invented by him, should be 1.
Therefore, his formula to determine a company's fair value is:
Peter Lynch Fair Value = Earnings Growth Rate * EPS * PEG
PEG is set to 1 so we can ignore it in the calculation. Based on the formula, if the earnings growth rate of a company is 15%, Peter Lynch is willing to buy its share up to P/E = 15.